Future directions in inflammatory bowel disease management.
Geert R D'Haens1, R Balfour Sartor2, Mark S Silverberg3
1Department of Gastroenterology, Academic Medical Centre, University of Amsterdam, The Netherlands.
Journal of Crohn'S & Colitis
|April 19, 2014
Summary
Future inflammatory bowel disease (IBD) management will integrate personalized medicine and advanced therapies. Strategies include early intervention, targeted biologics, microbiome manipulation, and an outcomes-based approach for better patient prognostication and treatment.
Area of Science:
- Gastroenterology and Immunology
- Translational Medicine
- Pharmacology
Background:
- Inflammatory bowel diseases (IBD) management is evolving with increased understanding of pathophysiology.
- New treatment modalities and personalized medicine are key areas of interest.
Purpose of the Study:
- To discuss potential future strategies for IBD management.
- To highlight advancements based on recent preclinical and clinical research.
Main Methods:
- Review of current and emerging IBD treatment strategies.
- Analysis of preclinical and clinical research findings.
Main Results:
- Adoption of a top-down approach for high-risk IBD patients to control inflammation early.
- Future use of biologics will be personalized, guided by biomarkers, with options for switching or combination therapy.
- Exploration of microbiome manipulation (diet, probiotics, fecal microbiota transplantation) and biosimilars.
Conclusions:
- Future IBD management requires an outcomes-based approach.
- Identifying biomarkers linked to biological processes is crucial for matching treatments to clinical endpoints.
- Personalized medicine will refine IBD classification, prognostication, and treatment.
More Related Videos
Related Concept Videos
01:29Inflammatory Bowel Disease IV: Pharmacological Management
1.1K
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
1.1K
01:21Inflammatory Bowel Disease V: Surgical Management
917
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
917
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
1.1K
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.1K
01:25Inflammatory Bowel Disease III: Crohn's Disease
35
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
35
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
34
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal...
34
01:26Inflammatory Bowel Disease I: Introduction
42
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows...
42